Aurobindo Pharma Limited
May 29, 2012 at 11:11 | Source: CNBC-TV18
May 29, 2012 at 08:28 | Source: CNBC-TV18
May 23, 2012 at 12:21 | Source: Moneycontrol.com
May 18, 2012 at 12:58 | Source: Moneycontrol.com
May 09, 2012 at 15:04 | Source: Moneycontrol.com
News across the web »
Feb 14, 2012 at 01:01 | Source: Business Standard
Nov 28, 2011 at 11:46 | Source: FirstPost
Interact & exchange stock tips & market info »
Hyderabad:Three persons were injured in an explosion at Aurobindo
12.50 PM Nov 28th 2011
Related News »
Aurobindo Pharma Limited has received final approval from US Food & Drug Administration (USGDA) for its tentatively approved ANDAs for Nevirapine Tablets 200 mg (ANDA 077521) and Nevirapine Oral Suspension 50mg/5mL (ANDA 077702). The products have a market ...
May 23, 2012 at 06:55 | Source: equitybulls.com
Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Clopidogrel Tablets USP 75 mg (ANDA 090540), which is being launched. Clopidogrel Tablets ...
May 18, 2012 at 10:57 | Source: 4-traders (press release)
Aurobindo Pharma Limited has pocketed final authorization from the US Food and Drug Administration (FDA) to produce and sell lamivudine and zidovudine tabs USP 150/300mg (ANDA 202418). Hyderabad-based pharma major said that it is ready to launch the ...
May 19, 2012 at 05:12 | Source: Top News India
Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market for Lamivudine & Zidovudine tablets USP 150/300 mg (ANDA 202418) and is ready for launch. Lamivudine & Zidovudine ...
May 16, 2012 at 07:17 | Source: equitybulls.com
Aurobindo Pharma Limited, Hyderabad-based pharma major, has received final approval from the US FDA to manufacture and market lamivudine and zidovudine tablets USP 150/300mg (ANDA 202418) and is ready for launch. Lamivudine and zidovudine tablets USP 150 ...
May 16, 2012 at 07:17 | Source: pharmabiz.com
Hyderabad-based pharmaceutical company Aurobindo Pharma limited (APL) on Wednesday stated that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Lamivudine and Zidovudine tablets. According to APL ...
May 16, 2012 at 08:36 | Source: Business Standard
Wockhardt hits lifetime high, soars 14% post Q4 results 23-MAY-12 Wockhardt Limited has rallied 6% to Rs 762 ... Torrent Pharmaceuticals Ltd and Aurobindo Pharma Ltd — have received approval from the US Food and Drug Administration (USFDA) to launch ...
May 27, 2012 at 06:57 | Source: Business Standard
Managing Directors Srinivasa Reddy (Hetero Drugs), Nityananda Reddy (Aurobindo Pharma), Sarat Chandra Reddy ... Jagati Publications (publisher of Sakshi Telugu daily) and Ramky Pharma India Limited have been named as the other accused in ...
May 8, 2012 at 16:17 | Source: Hindustan Times
Vijayalakshmi, and Aurobindo Pharma's former company secretary Chandramouli ... The court May 16 had remanded them in judicial custody till May 30. © 2012 IANS India Private Limited. All Rights Reserved. The reproduction of the story/photograph in ...
May 28, 2012 at 07:53 | Source: ianslive.in
Besides, representatives of Jagati Publications, Hetero, Aurobindo, Trident Life Sciences ... Jagati Publications (publisher of Sakshi Telugu daily) and Ramky Pharma India Limited have been named as the other accused in the case. CBI said Ramky had ...
May 8, 2012 at 03:02 | Source: firstpost.com